Multiethnic Tumor Models Aid in the Search for New Approaches Against Triple-Negative Breast Cancer

Breast cancer stem cells from patients with different racial and ethnic backgrounds showed important differences in activation of immune response-related genes in mouse models.

2:51 PM

Author | Ian Demsky

blue breast cancer cell image withia yellow badge saying lab note in blue font
Breast cancer cell by Anne Weston, Francis Crick Institute via Wellcome Collection. (CC BY-NC 4.0)

A team of researchers from the University of Michigan and the Henry Ford Health System is shedding new light on important differences in triple-negative breast cancer tumors from African, African American and white patients.

The work was conducted using mouse xenograft models implanted with patient breast tumors.

The findings, which recently appeared in Breast Cancer Research and Treatment, point toward several genes with significantly higher activity in tumors from Ghanaian and African American women — which could potentially serve as targets for developing new drugs.

Triple-negative breast cancer is more aggressive than other types of the disease and lacks targeted therapeutic options. It accounts for up to 25% of breast cancers in African American women and up to 80% in Ghanaians, which contributes to racial and ethnic disparities in overall outcomes.

"We found that women with African ancestry had enrichment of genes related to immune responses and processes in their cancer's stem cells," says study first author Evelyn M. Jiagge, M.D., Ph.D., a researcher at the Henry Ford Cancer Institute, and a trainee of senior author Sofia Merajver, M.D., Ph.D., director of the Breast and Ovarian Cancer Risk and Evaluation Program at the U-M Rogel Cancer Center and of co-author Max Wicha, M.D., director of the Forbes Institute for Cancer Discovery at U-M. "These genes included PD-L1, a marker of a critical checkpoint in cellular immune response which is thought to be a key molecule that helps tumors to suppress the body's natural immune response."

The work suggests further study into the role of immune-related genes in breast cancer stem cells may help develop new approaches to treat triple-negative breast cancer, and thus to help reduce survival disparities in women with African ancestry, Merajver adds.

Paper cited: "Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry," Breast Cancer Research and Treatment. DOI: 10.1007/s10549-021-06097-8

More Articles About: Lab Notes Breast cancer Cancer Research Demographics Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories
Health Lab
"Drawing Dad" becomes sensation throughout pediatric cancer unit
A form of art therapy for one dad brings joy to patients across his child's floor, also in-patient receiving treatments.
liver in bright green against navy background
Health Lab
Genetic variation with MASLD reveals subtypes and potential therapeutic avenues
A Michigan Medicine team of experts seeks to identify the human genetic causes of MASLD, formerly called NAFLD
cancer cell
Health Lab
Language barriers in cancer care
Research from experts at Michigan Medicine shows that significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor. 
blood sample
Health Lab
Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence
Early findings of two studies from the University of Michigan Rogel Cancer Center shed light on new ways to anticipate recurrence in HPV-positive head and neck cancer sooner. The papers, published in Cancer and Oral Oncology, offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow, and provide a framework for a new, more sensitive blood test that could help in this monitoring.
nanoparticles floating green blue
Health Lab
Gene therapy for brain tumor shows promising early results in humans
Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.
map green teal
Health Lab
As Medicaid ‘unwinding’ continues, Michigan report provides key insights
Medicaid expansion’s impact on low-income Michigan residents included reduced uninsurance, increased primary and preventive care, and better financial health.